Valuation — not yet established
No valuation for AltaThera Pharmaceuticals is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($7.6M) and the funding record below are the closest available signals.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
See the evidence behind this price
- ·Post-money valuations for all 5 rounds
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for AltaThera Pharmaceuticals
Create free account
No card required
Funding history
5 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Apr 2019 | Debt | $1.5M | ▮ | ▮ |
| Dec 2016 | Seed Round | $3.4M | ▮ | ▮ |
| Jul 2015 | Seed Round | $1.0M | ▮ | ▮ |
| Oct 2014 | Seed Round | $1.0M | ▮ | ▮ |
| Mar 2014 | Seed Round | $500K | ▮ | ▮ |
How AltaThera Pharmaceuticals's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For AltaThera Pharmaceuticals, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- How much has AltaThera Pharmaceuticals raised?
- AltaThera Pharmaceuticals has raised $7.6M in total funding across 5 recorded rounds.
- When did AltaThera Pharmaceuticals last raise?
- AltaThera Pharmaceuticals last raised in Apr 2019 (Debt), raising $1.5M.